ACRO Biomedical Co., Ltd. (TPEX:6748)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
66.60
-1.80 (-2.63%)
Feb 11, 2026, 1:59 PM CST
Market Cap4.19B +178.6%
Revenue (ttm)36.50M -35.2%
Net Income-79.82M
EPS-1.30
Shares Out61.22M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume413,217
Average Volume434,676
Open67.50
Previous Close68.40
Day's Range63.20 - 68.40
52-Week Range22.85 - 94.30
Beta0.47
RSI58.58
Earnings DateApr 16, 2026

About ACRO Biomedical

ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials. The company offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines. The company was founded in 2014 and is based in Kaohsiung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6748
Full Company Profile

Financial Performance

In 2024, ACRO Biomedical's revenue was 44.23 million, a decrease of -13.38% compared to the previous year's 51.06 million. Losses were -62.09 million, 49.9% more than in 2023.

Financial Statements